The erector spinae plane (ESP) block: A pooled review of 242 cases

The erector spinae plane block (ESPB) was first described in 2016 as a regional block for thoracic neuropathic pain. Given its short history, there are a paucity of controlled clinical trials, yet an abundance of case reports. The primary aim of this review is to examine pooled clinical data from pu...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical anesthesia Vol. 53; pp. 29 - 34
Main Authors: Tsui, Ban C.H., Fonseca, Ahtziri, Munshey, Farrukh, McFadyen, Grant, Caruso, Thomas J.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01.03.2019
Elsevier Limited
Subjects:
Analgesics
Anesthesia
Clinical trials
Erector spinae plane
Erector spinae plane block
Intubation
Joint surgery
Medical Subject Headings-MeSH
Narcotics
Pain Medicine
Patients
Pediatrics
Performance evaluation
Regional anesthesia
Spinal cord
Thoracic surgery
Erector spinae plane
Regional anesthesia
Erector spinae plane block
ISSN:0952-8180, 1873-4529, 1873-4529
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The erector spinae plane block (ESPB) was first described in 2016 as a regional block for thoracic neuropathic pain. Given its short history, there are a paucity of controlled clinical trials, yet an abundance of case reports. The primary aim of this review is to examine pooled clinical data from published literature to gain an understanding of ESPB characteristics. A PubMed search was conducted to identify all ESPB related publications. Inclusion criteria included reports of ESP single shot, continuous infusion, intermittent bolus, human and cadaveric studies. Only publications obtained in English were included. Measures included type of publication, year and country of publication, journal of publication, block technique, anatomic location, age, opioid and adjunct pain medication use, sensory and motor changes, side effects and adverse events. Qualitative statistics were used. The initial search yielded 201 publications. After application of inclusion and exclusion criteria, 85 publications from 21 journals were included in the pooled review which yielded 242 reported cases between 2016 and 2018. The majority of publications reported single shot techniques (80.2%), followed by intermittent boluses (12.0%) and continuous infusions (7.9%). 90.9% reported use of multimodal analgesia in addition to the ESPB and 34.7% reported sensory changes from ESPB. A reduction in opioid use was reported in 34.7% of cases. One adverse event involving a pneumothorax was reported. To our knowledge, this is the first review providing a pooled review of ESPB characteristics. The ESPB appears to be a safe and effective option for multiple types thoracic, abdominal, and extremity surgeries. •The rapid increase of publications from many countries indicates widespread adoption.•Reports have demonstrated analgesia at cervical, thoracic, and lumbar levels.•No cases of bleeding or hemodynamic effects
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Correspondence-2
content type line 14
ObjectType-Letter to the Editor-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0952-8180
1873-4529
1873-4529
DOI:10.1016/j.jclinane.2018.09.036